Stockreport

Keryx Bio's Auryxia shows potential in delaying dialysis in patients with advanced kidney disease [Seeking Alpha]

KERYX BIOPHARMACEUTICALS  (KERX) 
Last keryx biopharmaceuticals earnings: 11/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.keryx.com/investor-overview
PDF Keryx Bio's Auryxia shows potential in delaying dialysis in patients with advanced kidney diseaseResults from an open-label investigator-sponsored study assessing Keryx [Read more]